Quick Answer
Spirulina Cholesterol Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 2 2 2 Obesity constitutes a major global health concern, closely associated with a range of metabolic dysfunctions such as insulin resistance, dyslipidemia, and chronic systemic inflammation.
Key Takeaways
- 011 2 3 4 2 2 2 Obesity constitutes a major global health concern, closely associated with a range of metabolic dysfunctions such as insulin resistance, dyslipidemia, and chronic systemic inflammation. [Yasul Yavuz (2026)]
- 02These dysfunctions significantly elevate the risk of developing type 2 diabetes, cardiovascular disease, and other metabolic syndromes, underscoring the need for comprehensive and integrative interventions [,]. [Yasul Yavuz (2026)]
- 03According to the World Health Organization (WHO), individuals with a body mass index (BMI) ≥ 25 kg/m, encompassing both overweight (25.0–29.9 kg/m) and obese (≥30.0 kg/m) categories, are at increased cardiometabolic risk and were therefore included in this systematic review. [Yasul Yavuz (2026)]
- 04Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. [Rzeski Wojciech (2026)]
The current Migaku evidence database contains 2 reusable source documents for Spirulina Cholesterol Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation.
- 1 2 3 4 2 2 2 Obesity constitutes a major global health concern, closely associated with a range of metabolic dysfunctions such as insulin resistance, dyslipidemia, and chronic systemic inflammation. [Yasul Yavuz (2026); evidence level 1]
- These dysfunctions significantly elevate the risk of developing type 2 diabetes, cardiovascular disease, and other metabolic syndromes, underscoring the need for comprehensive and integrative interventions [,]. [Yasul Yavuz (2026); evidence level 1]
- According to the World Health Organization (WHO), individuals with a body mass index (BMI) ≥ 25 kg/m, encompassing both overweight (25.0–29.9 kg/m) and obese (≥30.0 kg/m) categories, are at increased cardiometabolic risk and were therefore included in this systematic review. [Yasul Yavuz (2026); evidence level 1]
- Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. [Rzeski Wojciech (2026); evidence level 3]
- We also discuss clinical evidence, safety considerations, and translational perspectives, highlighting current knowledge gaps and future research directions necessary for the rational development of microalgae-based interventions in preventive and integrative medicine. [Rzeski Wojciech (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources